biolab l carnitine L-Carnitine (500mg) NutraBio® - L-Carnitine 3000 -

Is Vitamin IV Therapy part of functional medicine

Or click one of the links below: GNTI-122-T1D-1001 This is a 78-week single arm, multi-center, Phase 1 study to evaluate the safety, tolerability, cellular kinetics, and biomarker changes in C-peptide over time of GNTI-122, an investigational cell therapy manufactured from a participant's own blood Investigator Brittany S Bruggeman Status Accepting Candidates Ages 18 Years - 55 Years Sexes All TN-36 This Phase 2 study is a 2-arm, multi-center, double-masked (masking of the participant, care provider and investigator), placebo-controlled, 2:1 randomized trial design in new onset T1D participants (within 100 days of diagnosis)

This approach identifies underlying health issues online surveys or rushed telemedicine might miss

Lutsenko MT, Andrievskaya IA, Kutepova OL